Cyanotic congenital heart defects: Pathology review

Cyanotic congenital heart defects: Pathology review

MD2_HDF_II

MD2_HDF_II

Antituberculosis medications
Cardiac work
Pressure-volume loops
Blood pressure, blood flow, and resistance
Pressures in the cardiovascular system
Laminar flow and Reynolds number
Measuring cardiac output (Fick principle)
Anatomy clinical correlates: Heart
Tricuspid valve disease
Pulmonary valve disease
Mitral valve disease
Aortic valve disease
Cardiomyopathies: Pathology review
Class I antiarrhythmics: Sodium channel blockers
Class II antiarrhythmics: Beta blockers
Class III antiarrhythmics: Potassium channel blockers
Class IV antiarrhythmics: Calcium channel blockers and others
Cardiac conduction system
Cardiac conduction velocity
ECG basics
ECG normal sinus rhythm
ECG rate and rhythm
ECG cardiac infarction and ischemia
Supraventricular arrhythmias: Pathology review
Ventricular arrhythmias: Pathology review
Heart failure: Pathology review
Cor pulmonale
Acyanotic congenital heart defects: Pathology review
Cyanotic congenital heart defects: Pathology review
Development of the cardiovascular system
Heart failure: Clinical
Adrenergic antagonists: Beta blockers
Loop diuretics
ACE inhibitors, ARBs and direct renin inhibitors
Dilated cardiomyopathy
Restrictive cardiomyopathy
Hypertrophic cardiomyopathy
Heart failure
Fetal circulation
Persistent truncus arteriosus
Transposition of the great vessels
Tetralogy of Fallot
Patent ductus arteriosus
Ventricular septal defect
Coarctation of the aorta
Atrial septal defect
Cardiac muscle histology
Hypertension: Pathology review
Hypertension
Thiazide and thiazide-like diuretics
Calcium channel blockers
Angina pectoris
Myocardial infarction
Peripheral artery disease
Atherosclerosis and arteriosclerosis: Pathology review
Aortic dissections and aneurysms: Pathology review
Vasculitis: Pathology review
Kawasaki disease
Anticoagulants: Heparin
Anticoagulants: Warfarin
Anticoagulants: Direct factor inhibitors
Antiplatelet medications
Thrombolytics
Reading a chest X-ray
The role of the kidney in acid-base balance
Acid-base map and compensatory mechanisms
Acid-base disturbances: Pathology review
Respiratory acidosis
Respiratory alkalosis
Metabolic acidosis
Metabolic alkalosis
Plasma anion gap
Obstructive lung diseases: Pathology review
Chronic obstructive pulmonary disease (COPD): Clinical
Asthma: Clinical
Alpha 1-antitrypsin deficiency
Bronchiectasis
Chronic bronchitis
Cystic fibrosis
Emphysema
Restrictive lung diseases
Idiopathic pulmonary fibrosis
Sarcoidosis
Deep vein thrombosis and pulmonary embolism: Pathology review
Pulmonary hypertension
Pulmonary edema
Tuberculosis: Pathology review
Pneumonia: Clinical
Chlamydia pneumoniae
Klebsiella pneumoniae
Mycoplasma pneumoniae
Streptococcus pneumoniae
Upper respiratory tract infection
Bacterial epiglottitis
Respiratory syncytial virus
Influenza virus
Mesothelioma
Bronchodilators: Leukotriene antagonists and methylxanthines
Bronchodilators: Beta 2-agonists and muscarinic antagonists

Transcript

Watch video only

At the pediatric cardiology clinic, two mothers were chatting about their kids. One mom spoke about a 5 year old boy named Blake, who was a bluish color at birth and had a continuous machine-like heart murmur between the scapulas.

Another mom spoke about her 12 year old son, Paul, who was healthy at birth, but when he was breastfeeding or crying, his skin turned pale, and then blue. As a child, Paul got out of breath easily and needed to squat down to recover. And during his school physical, he was found to have a heart murmur.

Both Blake and Paul have cyanotic congenital heart defects, or CHDs, which usually start causing problems within the first 3-8 weeks of life. They can be broadly grouped into life-threatening cyanotic heart defects, or the less dangerous acyanotic heart defects.

Let’s go over 5 of the life-threatening cyanotic congenital heart defects: persistent truncus arteriosus, transposition of the great vessels, tetralogy of fallot, total anomalous pulmonary venous return, and tricuspid atresia.

Now the first 3 are caused by outflow tract defects that develop during the formation of the aorta and pulmonary artery. In fetal development the heart looks like a long tube; the top part is the truncus arteriosus and the part inferior to that is the bulbus cordis. Neural crest cells migrate into the bulbus cordis and trigger the formation of the aorticopulmonary septum. This structure is formed when two endocardial cushions appear on the right-superior and left-inferior walls. These grow like a spiral - imagine a corkscrew - and they wrap around each other forming a single septum that divides the truncus into the roots of the aorta. One root connects to the primitive left ventricle, and the other connects to the pulmonary artery and primitive right ventricle. That’s how blood gets routed to the right place!

Okay, so if the aorticopulmonary septum doesn’t form, or forms incompletely, the result is a persistent truncus arteriosus. For your exams, it’s important to know that this is caused by the failure of neural crest cells to properly migrate to the bulbus cordis. So we end up with a single vessel that’s connected to both the left and right ventricle, allowing oxygenated blood and deoxygenated blood to mix. This large common trunk eventually divides into the aorta and the pulmonary artery, and both carry partially oxygenated blood. When the partially oxygenated blood goes out to the body, it causes cyanosis.

Okay, moving on. If the spiraling of the aorticopulmonary septum doesn’t occur at all, we get transposition of the great vessels, where the aorta connects to the right ventricle and the pulmonary artery connects to the left ventricle. Here, deoxygenated blood from the systemic circulation goes to the right side of the heart, and gets pumped out of the aorta again. Meanwhile, oxygenated blood from the lungs goes to the left side of the heart, and gets pumped back to the lungs. So, for the test, remember that we end up with 2 seperate closed systems. Another high yield fact is that the only way that a newborn can survive is with a Patent Ductus Arteriosus or PDA, an opening between the aorta and pulmonary artery that allows some of the oxygenated and deoxygenated blood to mix. But since the PDA normally closes soon after birth it has to be kept open to keep a newborn alive.

Now, there’s tetralogy of Fallot, which is the most common cyanotic congenital heart defect. And “tetralogy” refers to four main features that you absolutely have to remember! First, a part of the right ventricle wall under the outflow tract, called the infundibular septum, is displaced anteriorly which narrows the right ventricular outflow tract, leading to pulmonary stenosis. Second, the narrowing of the right ventricular outflow tract increases resistance to blood flow, so the myocardium of the right ventricle hypertrophies to overcome that resistance. On x-ray the enlarged heart looks like a boot. Third, there’s a VSD, a tiny hole, between the ventricles that allows blood to shunt across. Initially, the left sided pressures are higher so blood flows to the right, but over time right sided pressures get so high that blood flows to the left - this is called Eisenmenger’s syndrome, which is very important to remember. In other words, some of the deoxygenated blood bypasses the lungs and goes to the left vent ricle. Fourth, there’s a displaced aorta that sits right above the ventricular septal defect, and this is called an overriding aorta.

Sources

  1. "Pathophysiology of Heart Disease" Wolters Kluwer Health (2015)
  2. "Robbins Basic Pathology" Elsevier (2017)
  3. "Harrison's Principles of Internal Medicine, Twentieth Edition (Vol.1 & Vol.2)" McGraw-Hill Education / Medical (2018)
  4. "Cyanosis of the newborn infant" The Journal of Pediatrics (1970)
  5. "Diagnosis and management of the newborn with suspected congenital heart disease" Clin Perinatol (2001)